Heartland Group Holdings Limited (HGH.NZ)
- Previous Close
1.0600 - Open
1.0800 - Bid 1.0600 x 5240300
- Ask 1.0700 x 253600
- Day's Range
1.0600 - 1.0800 - 52 Week Range
1.0200 - 1.8400 - Volume
547,683 - Avg. Volume
1,140,280 - Market Cap (intraday)
813.448M - Beta (5Y Monthly) 0.96
- PE Ratio (TTM)
8.83 - EPS (TTM)
0.1200 - Earnings Date Feb 26, 2024
- Forward Dividend & Yield 0.10 (9.22%)
- Ex-Dividend Date Mar 5, 2024
- 1y Target Est
1.29
Heartland Group Holdings Limited provides various financial services in New Zealand and Australia. The company offers savings accounts, term deposits, and direct and business call accounts. It also provides home loans, business loans, term loans, revolving credit, car loans, and reverse mortgage lending and other financial services. In addition, the company offers term debt, plant and equipment finance, commercial mortgage lending, and working capital solutions for small-to-medium sized businesses; and livestock finance, rural mortgage lending, and seasonal and working capital financing, as well as leasing solutions to farmers. Further, it provides internet and mobile banking services; and management and insurance services, as well as engages in the investment property holding business. Heartland Group Holdings Limited was founded in 1875 and is based in Auckland, New Zealand.
shareholders.heartland.co.nzRecent News: HGH.NZ
Performance Overview: HGH.NZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HGH.NZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HGH.NZ
Valuation Measures
Market Cap
776.51M
Enterprise Value
--
Trailing P/E
9.07
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.74
Price/Book (mrq)
0.76
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
34.10%
Return on Assets (ttm)
1.10%
Return on Equity (ttm)
8.33%
Revenue (ttm)
248.67M
Net Income Avi to Common (ttm)
84.81M
Diluted EPS (ttm)
0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
178.55M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: HGH.NZ
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: HGH.NZ
HGH.NZ does not have Company Insights